← back to search

David Goldsmith

Emory University · US
Area of research
Nephrology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Parathyroid Disorders and Treatments, Dialysis and Renal Disease Management, Blood Pressure and Hypertension Studies, and Chronic Kidney Disease and Diabetes.
h-index
75
citations
18,016
works
642
NIH funding
primary concept
email

Recent publications

The Potential Role for a Painless Enzymatic Debridement Gel in Wound Bed Preparation for Venous Leg Ulcers-A Dose Escalation Study.
2025cited by 0position: contributordoi
First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers.
2024cited by 3position: contributordoi
Renal and Urological Disorders Associated With Inflammatory Bowel Disease.
2023cited by 31position: contributordoi
The role of flavored electronic nicotine delivery systems in smoking cessation: A systematic review.
2023cited by 22position: contributordoi
Epoetin alfa biosimilar (HX575): A review of 15 years' post-approval clinical experience.
2023cited by 3position: contributordoi
GFR, Race, and Implications.
2023cited by 1position: contributordoi
The art and science of the possible in glomerular filtration rate measurement.
2022cited by 1position: contributordoi
Personal pandemic experiences must be recorded, replayed, and respected.
2022cited by 0position: contributordoi
Impact of vitamin D on cardiac structure and function in chronic kidney disease patients with hypovitaminosis D: a randomized controlled trial and meta-analysis.
2021cited by 12position: contributordoi
Oncogenic mechanisms in renal insufficiency.
2021cited by 11position: contributordoi
Nomenclature in nephrology: preserving 'renal' and 'nephro' in the glossary of kidney health and disease.
2021cited by 9position: contributordoi
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
2020cited by 309position: contributordoi
Four months into the COVID-19 pandemic, Sweden's prized <i>herd immunity</i> is nowhere in sight.
2020cited by 46position: contributordoi
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2019cited by 470position: middledoi
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation
Journal of the American College of Cardiology 2019cited by 167position: lastdoi
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.
2019cited by 106position: contributordoi
Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease.
2019cited by 26position: contributordoi
Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease.
2019cited by 13position: contributordoi
Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study.
2019cited by 3position: contributordoi
Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care
BMJ 2018cited by 84position: middledoi
Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
Clinical Kidney Journal 2018cited by 43position: middledoi
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population
The Lancet Diabetes & Endocrinology 2017cited by 157position: middledoi
Long-term pulse wave velocity outcomes with aerobic and resistance training in kidney transplant recipients – A pilot randomised controlled trial
PLoS ONE 2017cited by 47position: middledoi
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Kidney International 2016cited by 474position: middledoi
Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?
Nephrology Dialysis Transplantation 2016cited by 59position: middledoi
Assessment and Management of Hypertension in Transplant Patients
Journal of the American Society of Nephrology 2015cited by 184position: middledoi
The double challenge of resistant hypertension and chronic kidney disease
The Lancet 2015cited by 182position: middledoi
Pro: Cardiovascular calcifications are clinically relevant
Nephrology Dialysis Transplantation 2015cited by 57position: middledoi
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
The Lancet 2014cited by 430position: middledoi
Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Nephrology Dialysis Transplantation 2014cited by 109position: middledoi

Grants

Purchase of a Routine High-Field NMR Spectrometer (Chemistry)
NSF8516614$115,0001985–1986PIRePORTER

Frequent collaborators

Ziad A. Massy · Imperial College Healthcare NHS Trust10 papers (2012–2018)Gérard M. London · Indiana University School of Medicine8 papers (2012–2015)Andrzej Więcek · Launchpad Central (United States)8 papers (2012–2015)Adrian Covic · Indiana University – Purdue University Indianapolis8 papers (2012–2019)Carmine Zoccali · Target (United States)6 papers (2012–2015)Alberto Ortíz · Department of Public Health6 papers (2012–2015) · 6 papers (2012–2018) · 5 papers (2020–2025) · 5 papers (2014–2018)Vincent Brandenburg · University Hospital Heidelberg5 papers (2014–2018)Marc Vervloet · Utrecht University5 papers (2014–2018) · 4 papers (2012–2013) · 4 papers (2014–2018)Danilo Fliser · Saarland University4 papers (2012–2013)Bengt Lindholm · Karolinska Institutet4 papers (2012–2013) · 3 papers (2012–2013)Pieter Evenepoel · KU Leuven3 papers (2016–2018)Adrian Covic · Koç University3 papers (2019–2021) · 3 papers (2016–2018)Denis Fouque · University of Groningen3 papers (2013–2015)